Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

150,000-year palaeoclimate record from northern Ethiopia supports early, multiple dispersals of modern humans from Africa.

Lamb HF, Bates CR, Bryant CL, Davies SJ, Huws DG, Marshall MH, Roberts HM.

Sci Rep. 2018 Jan 18;8(1):1077. doi: 10.1038/s41598-018-19601-w.

2.

Evidence for a bi-partition of the Younger Dryas Stadial in East Asia associated with inversed climate characteristics compared to Europe.

Schlolaut G, Brauer A, Nakagawa T, Lamb HF, Tyler JJ, Staff RA, Marshall MH, Bronk Ramsey C, Bryant CL, Tarasov PE.

Sci Rep. 2017 Mar 31;7:44983. doi: 10.1038/srep44983.

3.

A complete terrestrial radiocarbon record for 11.2 to 52.8 kyr B.P.

Bronk Ramsey C, Staff RA, Bryant CL, Brock F, Kitagawa H, van der Plicht J, Schlolaut G, Marshall MH, Brauer A, Lamb HF, Payne RL, Tarasov PE, Haraguchi T, Gotanda K, Yonenobu H, Yokoyama Y, Tada R, Nakagawa T.

Science. 2012 Oct 19;338(6105):370-4. doi: 10.1126/science.1226660.

4.

Three partial-task simulators for teaching ultrasound-guided regional anesthesia.

Rosenberg AD, Popovic J, Albert DB, Altman RA, Marshall MH, Sommer RM, Cuff G.

Reg Anesth Pain Med. 2012 Jan-Feb;37(1):106-10. doi: 10.1097/AAP.0b013e31823699ab.

PMID:
22189577
5.

In vitro cytotoxicity of hepsulfam against human tumor cell lines and primary human tumor colony forming units.

Marshall MV, Marshall MH, Degen DR, Roodman GD, Kuhn JG, Ross ME, Von Hoff DD.

Stem Cells. 1993 Jan;11(1):62-9.

PMID:
8457783
6.

Activity of topotecan, a new topoisomerase I inhibitor, against human tumor colony-forming units in vitro.

Burris HA 3rd, Hanauske AR, Johnson RK, Marshall MH, Kuhn JG, Hilsenbeck SG, Von Hoff DD.

J Natl Cancer Inst. 1992 Dec 2;84(23):1816-20.

PMID:
1331485
7.

Lack of effects of recombinant human interleukin-4 on in vitro colony formation of freshly explanted human tumor cells.

Hanauske AR, Degen D, Marshall MH, Trotta PP, Von Hoff DD.

Invest New Drugs. 1992 Nov;10(4):269-73.

PMID:
1487400
8.

Activity of a recombinant transforming growth factor-alpha-Pseudomonas exotoxin hybrid protein against primary human tumor colony-forming units.

Von Hoff DD, Marshall MH, Heimbrook DC, Stirdivant SM, Ahern JD, Herbert WK, Maigetter RZ, Oliff A.

Invest New Drugs. 1992 Apr;10(1):17-22.

PMID:
1607249
9.

Activity of 2',2'-difluorodeoxycytidine (Gemcitabine) against human tumor colony forming units.

Hanauske AR, Degen D, Marshall MH, Hilsenbeck SG, Grindey GB, Von Hoff DD.

Anticancer Drugs. 1992 Apr;3(2):143-6.

PMID:
1525392
10.

Effects of recombinant human interleukin-1 alpha on clonogenic growth of primary human tumors in vitro.

Hanauske AR, Degen D, Marshall MH, Hilsenbeck SG, Banks P, Stuckey J, Leahy M, Von Hoff DD.

J Immunother (1991). 1992 Apr;11(3):155-8.

PMID:
1515420
11.

Preclinical activity of ilmofosine against human tumor colony forming units in vitro.

Hanauske AR, Degen D, Marshall MH, Hilsenbeck SG, McPhillips JJ, Von Hoff DD.

Anticancer Drugs. 1992 Feb;3(1):43-6.

PMID:
1623215
12.

Regulatory improvements spur utilization of Medicare.

Gong J, Marshall MH.

Provider. 1991 Aug;17(8):44, 46-7. No abstract available.

PMID:
10124762
13.

In vitro assessment of the effects of granulocyte-macrophage colony-stimulating factor on primary human tumors and derived lines.

Foulke RS, Marshall MH, Trotta PP, Von Hoff DD.

Cancer Res. 1990 Oct 1;50(19):6264-7. Review.

14.

Biphasic effect of vanadium salts on in vitro tumor colony growth.

Hanauske U, Hanauske AR, Marshall MH, Muggia VA, Von Hoff DD.

Int J Cell Cloning. 1987 Mar;5(2):170-8.

PMID:
3106514
15.

Use of in vitro dose response effects to select antineoplastics for high-dose or regional administration regimens.

Von Hoff DD, Clark GM, Weiss GR, Marshall MH, Buchok JB, Knight WA 3rd, LeMaistre CF.

J Clin Oncol. 1986 Dec;4(12):1827-34.

PMID:
2431110
16.

The treatment team: essential in the long-term rehabilitation of the stroke patient.

Marshall MH, Levy H.

J Med Assoc Ga. 1986 Feb;75(2):98-101. No abstract available.

PMID:
3083035
18.

Dietary techniques in metabolic work.

Marshall MH.

J Hum Nutr. 1977 Oct;31(5):356-8. No abstract available.

PMID:
915259
19.

Letter: Outplacement physical exams.

Marshall MH.

J Occup Med. 1975 Jan;17(1):6. No abstract available.

PMID:
1123683
20.

Letter: Behavior and stress.

Marshall MH.

JAMA. 1974 Aug 19;229(8):1045. No abstract available.

PMID:
4407949
21.

Persistent dyskinesias in drug users.

Marshall MH.

JAMA. 1972 Jul 3;221(1):86-7. No abstract available.

PMID:
5067771
22.

The psychopharmacology of depression: perspectives in research.

Marshall MH.

Psychosomatics. 1971 Jan-Feb;12(1):49-55. No abstract available.

PMID:
5545628
23.

Lithium, creativity, and manic-depressive illness: review and prospectus.

Marshall MH, Neumann CP, Robinson M.

Psychosomatics. 1970 Sep-Oct;11(5):406-8. No abstract available.

PMID:
5470661
24.

Are there "benefits" of mental illness?

Marshall MH.

Behav Neuropsychiatry. 1970 Jun-Jul;2(3):40-2. No abstract available.

PMID:
5426281
25.

The diagnostic clue of "hypercompetency".

Marshall MH, Resnik HL.

Am J Psychiatry. 1968 Oct;125(4):570-2. No abstract available.

PMID:
5711823
26.

Septic abortion, crisis care.

Marshall MH.

Am J Nurs. 1966 May;66(5):1042-4. No abstract available.

PMID:
5177040
27.

INSERVICE PROGRAMS REQUIRE EFFECTIVE FOLLOW-UP.

MARSHALL MH.

Nurs Outlook. 1964 Aug;12:42-4. No abstract available.

PMID:
14180909
28.

The response of the clotting equilibrium to postoperative stress.

DE TAKATS G, MARSHALL MH.

Surgery. 1952 Jan;31(1):13-27. No abstract available.

PMID:
14901234

Supplemental Content

Loading ...
Support Center